Goop Reaches Settlement in False Advertising Lawsuit

Share this content:
Goop Reaches Settlement in False Advertising Lawsuit
Goop Reaches Settlement in False Advertising Lawsuit

THURSDAY, Sept. 6, 2018 (HealthDay News) -- A $145,000 settlement will be paid by actress Gwyneth Paltrow's company, Goop, in a lawsuit over unfounded claims that some of its products improve women's sexual and emotional health.

The lawsuit was filed by prosecutors from 10 California counties. They said Goop did not have scientific proof for health claims made for three products sold online: jade and quartz vaginal eggs and a mix of essential oils, CBS News reported. The vaginal eggs were marketed as a way to "balance hormones, regulate menstrual cycles… and increase bladder control," while the mix of essential oils was advertised as a way to "help prevent depression."

"People have been selling snake oil for a long time. This is just another type of snake oil," said Orange County District Attorney Tony Rackauckas, CBS News reported. As part of the settlement, Goop will offer refunds to customers who request them. The three items are still on Goop's website but the descriptions have been changed.

"Health and wellness is a very hot industry and part and parcel with that, we're seeing a significant rise in misleading and deceptive marking claims," Bonnie Patten, executive director of Truth in Advertising, told CBS News. "Any time a consumer sees a product that's being marketed as a treatment or cure all… they need to be wary of that and they should definitely talk to a health care provider before purchasing it," she added.

CBS News Article

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »